PYROXD1
Basic information
Region (hg38): 12:21437615-21471250
Links
Phenotypes
GenCC
Source:
- myofibrillar myopathy 8 (Strong), mode of inheritance: AR
- myofibrillar myopathy 8 (Moderate), mode of inheritance: AR
- myofibrillar myopathy 8 (Definitive), mode of inheritance: AR
- myofibrillar myopathy 8 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Myopathy, myofibrillar 8 | AR | Cardiovascular | Though not common, some individuals can have cardiovascular manifestations, and awareness can allow medical management | Cardiovascular; Musculoskeletal | 27745833; 30345904; 30515627; 32037607; 33694278 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (295 variants)
- Inborn_genetic_diseases (59 variants)
- Myofibrillar_myopathy_8 (16 variants)
- PYROXD1-related_disorder (6 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PYROXD1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000024854.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 56 | 59 | ||||
| missense | 139 | 10 | 153 | |||
| nonsense | 3 | |||||
| start loss | 0 | |||||
| frameshift | 11 | |||||
| splice donor/acceptor (+/-2bp) | 11 | |||||
| Total | 15 | 12 | 141 | 66 | 3 |
Highest pathogenic variant AF is 0.00019409128
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PYROXD1 | protein_coding | protein_coding | ENST00000240651 | 12 | 32752 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 6.30e-9 | 0.870 | 125670 | 0 | 78 | 125748 | 0.000310 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.0969 | 252 | 256 | 0.983 | 0.0000123 | 3285 |
| Missense in Polyphen | 60 | 78.034 | 0.7689 | 989 | ||
| Synonymous | 0.0292 | 91 | 91.4 | 0.996 | 0.00000476 | 907 |
| Loss of Function | 1.69 | 17 | 26.4 | 0.644 | 0.00000140 | 345 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000949 | 0.000946 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000218 | 0.000217 |
| Finnish | 0.0000468 | 0.0000462 |
| European (Non-Finnish) | 0.000369 | 0.000352 |
| Middle Eastern | 0.000218 | 0.000217 |
| South Asian | 0.000284 | 0.000261 |
| Other | 0.000503 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in cellular response to oxidative stress. {ECO:0000269|PubMed:27745833}.;
- Disease
- DISEASE: Myopathy, myofibrillar, 8 (MFM8) [MIM:617258]: A form of myofibrillar myopathy, a group of chronic neuromuscular disorders characterized at ultrastructural level by disintegration of the sarcomeric Z disk and myofibrils, and replacement of the normal myofibrillar markings by small dense granules, or larger hyaline masses, or amorphous material. MFM8 is an autosomal recessive form, clinically characterized by slowly progressive symmetrical weakness affecting both proximal and distal muscles, with normal to moderately elevated creatine kinase. Mild facial weakness, a high palate, nasal speech, and swallowing difficulties are typical features, mild restrictive lung disease is common, and late-onset cardiac involvement may be present. {ECO:0000269|PubMed:27745833}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0932
Intolerance Scores
- loftool
- 0.499
- rvis_EVS
- -0.53
- rvis_percentile_EVS
- 20.7
Haploinsufficiency Scores
- pHI
- 0.0832
- hipred
- N
- hipred_score
- 0.251
- ghis
- 0.588
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.712
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pyroxd1
- Phenotype
- growth/size/body region phenotype; skeleton phenotype; digestive/alimentary phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype;
Zebrafish Information Network
- Gene name
- pyroxd1
- Affected structure
- skeletal muscle
- Phenotype tag
- abnormal
- Phenotype quality
- broken
Gene ontology
- Biological process
- cellular response to oxidative stress;oxidation-reduction process
- Cellular component
- nucleus;sarcomere
- Molecular function
- protein binding;oxidoreductase activity